Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
959760011000036116 | Irinotecan Hydrochloride Trihydrate (GA) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
959761011000036111 | Irinotecan Hydrochloride Trihydrate (GA) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Irinotecan Hydrochloride Trihydrate (GA) | Is a | trade product | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Irinotecan Hydrochloride Trihydrate (GA) 100 mg/5 mL injection, 5 mL vial | has TP | True | Irinotecan Hydrochloride Trihydrate (GA) | Inferred relationship | Some | |
Irinotecan Hydrochloride Trihydrate (GA) 40 mg/2 mL injection, 2 mL vial | Is a | True | Irinotecan Hydrochloride Trihydrate (GA) | Inferred relationship | Some | |
Irinotecan Hydrochloride Trihydrate (GA) 40 mg/2 mL injection, 2 mL vial | has TP | True | Irinotecan Hydrochloride Trihydrate (GA) | Inferred relationship | Some | |
Irinotecan Hydrochloride Trihydrate (GA) 100 mg/5 mL injection, 5 mL vial | Is a | True | Irinotecan Hydrochloride Trihydrate (GA) | Inferred relationship | Some | |
Irinotecan Hydrochloride Trihydrate (GA) 100 mg/5 mL injection, 5 mL vial | has TP | True | Irinotecan Hydrochloride Trihydrate (GA) | Inferred relationship | Some | |
Irinotecan Hydrochloride Trihydrate (GA) 40 mg/2 mL injection, 2 mL vial | has TP | True | Irinotecan Hydrochloride Trihydrate (GA) | Inferred relationship | Some |
Reference Sets